SNBR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Sleep Number Corp (SNBR) is not a strong buy for a beginner, long-term investor at this time. While the company has shown some signs of recovery in its financials and operational improvements, the technical indicators are bearish, options sentiment is weak, and analysts have significantly lowered price targets. The lack of recent positive trading signals and the stock's oversold condition suggest caution. Holding off on investment until more favorable conditions emerge is recommended.
The technical indicators for SNBR are bearish. The MACD histogram is negative (-0.178) and contracting, RSI_6 is extremely oversold at 8.317, and moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). Support levels are weak, with the stock trading near S1 (2.995) and far below the pivot (4.248).
Q4 revenue exceeded expectations despite a YoY decline.
Adjusted EPS for Q4 was significantly higher than expected.
Same-store sales rose 7% YoY, indicating potential recovery.
Management surpassed 2025 performance guidance and expressed confidence in 2026 growth.
Analysts have significantly lowered price targets (UBS: $4, Piper Sandler: $5).
Gross margin dropped by 2.46% YoY, and operating margin is negative (-2.3%).
Stock fell 6% post-earnings despite strong results, reflecting market uncertainty.
Technical indicators are bearish, and the stock is trading near key support levels.
In Q4 2025, revenue dropped by 7.81% YoY to $347.4 million. However, net income improved significantly to -$58.51 million (up 1154.23% YoY), and EPS increased to -$2.55 (up 1114.29% YoY). Adjusted EBITDA reached $19.4 million, supported by $185 million in annualized cost reductions. Gross margin declined to 58.39%, down 2.46% YoY.
Analysts have a Neutral stance on SNBR. UBS lowered its price target from $10 to $4, and Piper Sandler reduced its target from $12 to $5, citing lack of sales improvement despite operational progress. Earlier optimism about the new CEO has waned due to limited impact on sales growth.
